Cytosorbents Corporation

Clinical trials sponsored by Cytosorbents Corporation, explained in plain language.

Cytosorbents Corporation CTSO NASDAQ

Develops blood purification technologies for critical care.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1

Massive registry launched to see if Blood-Filtering device helps sickest patients

Knowledge-focused Recruiting now

This registry is tracking 3,000 critically ill patients who receive the CytoSorb blood-filtering device in real-world intensive care settings. The goal is to collect data on how the device is used and whether it relates to patient survival. It covers many conditions like sepsis, …

Sponsor: CytoSorbents, Inc • Aim: Knowledge-focused

Last updated Jun 26, 2026 15:43 UTC

Cytosorbents Corporation

Massive registry launched to see if Blood-Filtering device helps sickest patients